Austin American-Statesman March 12, 2023
Nicole Villalpando

Health care will be more personalized because that’s what consumers want, said Anne Wojcicki, the co-founder and CEO of 23andMe genomics profile company, in a conversation with Bloomberg’s Emily Chang on Friday afternoon at South by Southwest.

Here are five takeaways from that conversation:

AI is here to stay

“I remember in ’99 and 2000 when people were hypothesizing about the internet,” Wojcicki said. … “This is a moment where things are shifting.”

It’s not a question of whether to use artificial intelligence, but how to use it, she said.

“The...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), Biotechnology, Conferences / Podcast, Patient / Consumer, Pharma / Biotech, Precision Medicine, Provider, Technology, Trends
More than half of US adults could benefit from GLP-1 medications, researchers find
RNA editing is the next frontier in gene therapy—here's what you need to know
Rand roadblock: Biotech bill’s uncertain future
How Digital Chemistry Will Improve Cross-Functional Collaboration In The Biopharma Industry
GLP-1 drug coverage for obesity making inroads with large employers: Mercer

Share This Article